medigraphic.com
ENGLISH

Annals of Hepatology

Órgano Oficial de la Asociación Mexicana de Hepatología
  • Mostrar índice
  • Números disponibles
  • Información
    • Información general        
    • Directorio
  • Publicar
    • Instrucciones para autores        
  • medigraphic.com
    • Inicio
    • Índice de revistas            
    • Registro / Acceso
  • Mi perfil

2003, Número 1

<< Anterior Siguiente >>

Ann Hepatol 2003; 2 (1)


Terbinafine hepatotoxicity. A case report and review of literature

Zapata GAJ, Casillas RA, Bosques PF
Texto completo Cómo citar este artículo

Idioma: Ingles.
Referencias bibliográficas: 17
Paginas: 47-51
Archivo PDF: 140.81 Kb.


PALABRAS CLAVE

Sin palabras Clave

FRAGMENTO

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-5.

  2. Lewis JH, Zimmerman HJ. Drug-induced liver disease. Med Clin N Am 1989; 73: 775-92.

  3. Pillans PI. Drug associated hepatic reactions in New Zealand: 21 years experience. N Z Med J 1996; 109: 315-9.

  4. Ostapowicz G, Fontana RJ, Larson AM, et al. Etiology and outcome of acute liver failure in the USA: preliminary results of a prospective multi-center study. Hepatology 1999; 30: 221A.

  5. Fernandes NF, Geller SA, Fong T. Terbinafine hepatotoxicity : Case report and review of the literature. Am J Gastroenterol 1998; 93: 459-60.

  6. Zimmerman HJ. Hepatotoxicity. 2nd ed. Philadelphia: Lippincott, Williams & Wilkins, 1999.

  7. Benichou C. International consensus meeting: criteria of drug-induced liver disorders. J Hepatol 1990; 11: 272-6.

  8. Aithal GP, Rawlilns MD, Day CP. Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. J Hepatol 2000; 33: 949-52.

  9. Danan G, Benichou C. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46: 1331-6.

  10. Lucena MA, Camargo R, Andrade RJ, et al. Comparison of two clinical scales for causality assessment in hepatotoxicity. Hepatology 2001; 33: 123-30.

  11. Maria VAJ, Victorino RMM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 1997; 26: 664-9.

  12. Irey NB. Tissue reactions to drugs. Am J Pathol 1976; 82: 617-48.

  13. Irey NB. When is a disease drug-induced? In: Riddell RH, editor. Pathology of drug-induced and toxic diseases. New York: Churchill Livingstone, 1982; 1-18.

  14. Physicians’ Desk Reference. 55th ed. Medical Economics, 2001.

  15. Farrell GC. Drug-induced liver disease. Edinburgh: Churchill Livingstone, 1994.

  16. Stricker BHC. Drug-induced hepatic injury. 2nd ed. Amsterdam: Elsevier, 1992.

  17. Zimmerman HJ, Ishak KG. Hepatic injury due to drugs and toxins. In: MacSween RMN, Burt AD, Portmann BC, Ishak KG, Scheuer PJ, Anthony PP, eds. Pathology of the liver. London,




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ann Hepatol. 2003;2

ARTíCULOS SIMILARES

CARGANDO ...